MX2020010929A - Metodos para tratar el dolor neuropatico. - Google Patents
Metodos para tratar el dolor neuropatico.Info
- Publication number
- MX2020010929A MX2020010929A MX2020010929A MX2020010929A MX2020010929A MX 2020010929 A MX2020010929 A MX 2020010929A MX 2020010929 A MX2020010929 A MX 2020010929A MX 2020010929 A MX2020010929 A MX 2020010929A MX 2020010929 A MX2020010929 A MX 2020010929A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- neuropathic pain
- treating neuropathic
- treating
- prolinamide
- Prior art date
Links
- 208000004296 neuralgia Diseases 0.000 title 1
- 208000021722 neuropathic pain Diseases 0.000 title 1
- JESCETIFNOFKEU-SJORKVTESA-N (2s,5r)-5-[4-[(2-fluorophenyl)methoxy]phenyl]pyrrolidine-2-carboxamide Chemical compound N1[C@H](C(=O)N)CC[C@@H]1C(C=C1)=CC=C1OCC1=CC=CC=C1F JESCETIFNOFKEU-SJORKVTESA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862658347P | 2018-04-16 | 2018-04-16 | |
| PCT/US2019/027158 WO2019204136A1 (en) | 2018-04-16 | 2019-04-12 | Methods of treating neuropathic pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020010929A true MX2020010929A (es) | 2020-11-06 |
Family
ID=68239826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020010929A MX2020010929A (es) | 2018-04-16 | 2019-04-12 | Metodos para tratar el dolor neuropatico. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210154170A1 (https=) |
| EP (1) | EP3781157A4 (https=) |
| JP (1) | JP2021521227A (https=) |
| KR (1) | KR20210002472A (https=) |
| CN (1) | CN112367990A (https=) |
| AU (1) | AU2019255519A1 (https=) |
| BR (1) | BR112020021101A2 (https=) |
| CA (1) | CA3093401A1 (https=) |
| EA (1) | EA202092482A1 (https=) |
| IL (1) | IL277962A (https=) |
| MX (1) | MX2020010929A (https=) |
| SG (1) | SG11202008681PA (https=) |
| TW (2) | TW202245750A (https=) |
| WO (1) | WO2019204136A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2264182A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
| TW200730494A (en) * | 2005-10-10 | 2007-08-16 | Glaxo Group Ltd | Novel compounds |
| GB201409851D0 (en) * | 2014-06-03 | 2014-07-16 | Convergence Pharmaceuticals | Diagnostic method |
| GB201417497D0 (en) * | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
| JP2019537601A (ja) * | 2016-11-02 | 2019-12-26 | バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． | 新規投薬レジメン |
-
2019
- 2019-04-12 KR KR1020207028395A patent/KR20210002472A/ko not_active Withdrawn
- 2019-04-12 BR BR112020021101-0A patent/BR112020021101A2/pt not_active Application Discontinuation
- 2019-04-12 EP EP19787899.4A patent/EP3781157A4/en not_active Withdrawn
- 2019-04-12 CN CN201980026095.5A patent/CN112367990A/zh not_active Withdrawn
- 2019-04-12 US US17/047,570 patent/US20210154170A1/en not_active Abandoned
- 2019-04-12 JP JP2020556855A patent/JP2021521227A/ja not_active Withdrawn
- 2019-04-12 SG SG11202008681PA patent/SG11202008681PA/en unknown
- 2019-04-12 EA EA202092482A patent/EA202092482A1/ru unknown
- 2019-04-12 WO PCT/US2019/027158 patent/WO2019204136A1/en not_active Ceased
- 2019-04-12 CA CA3093401A patent/CA3093401A1/en not_active Withdrawn
- 2019-04-12 AU AU2019255519A patent/AU2019255519A1/en not_active Withdrawn
- 2019-04-12 MX MX2020010929A patent/MX2020010929A/es unknown
- 2019-04-16 TW TW111111744A patent/TW202245750A/zh unknown
- 2019-04-16 TW TW108113193A patent/TWI803619B/zh not_active IP Right Cessation
-
2020
- 2020-10-12 IL IL277962A patent/IL277962A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021521227A (ja) | 2021-08-26 |
| TWI803619B (zh) | 2023-06-01 |
| US20210154170A1 (en) | 2021-05-27 |
| CA3093401A1 (en) | 2019-10-24 |
| AU2019255519A1 (en) | 2020-10-01 |
| IL277962A (en) | 2020-11-30 |
| SG11202008681PA (en) | 2020-10-29 |
| TW202245750A (zh) | 2022-12-01 |
| EA202092482A1 (ru) | 2021-03-30 |
| BR112020021101A2 (pt) | 2021-02-23 |
| CN112367990A (zh) | 2021-02-12 |
| EP3781157A1 (en) | 2021-02-24 |
| KR20210002472A (ko) | 2021-01-08 |
| WO2019204136A1 (en) | 2019-10-24 |
| EP3781157A4 (en) | 2022-01-26 |
| TW201946619A (zh) | 2019-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202191177A1 (ru) | 2-амино-n-гетероарилникотинамиды в качестве ингибиторов nav1.8 | |
| JOP20200309A1 (ar) | أجسام مضادة لـ il-11 | |
| MX2021000148A (es) | Inhibidores eterociclicos de erk1 y erk2 y su uso en el tratamiento del cancer. | |
| MX2020011653A (es) | Métodos de tratamiento para el abuso de sustancias. | |
| EP4041212C0 (en) | MEK INHIBITORS FOR THE TREATMENT OF HANTAVIRUS INFECTIONS | |
| ZA202001717B (en) | Compounds, salts thereof and methods for treatment of diseases | |
| MX392869B (es) | Kit para el tratamiento o alivio de dolor en el sitio de incision despues de un procedimiento quirurgico | |
| SG10201907819WA (en) | N-((het)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors, | |
| PH12020552214A1 (en) | Ectonucleotidase inhibitors and methods of use thereof | |
| PH12021550887A1 (en) | 5-membered heteroaryl carboxamide compounds for treatment of hbv | |
| BR112017011900A2 (pt) | tratamento de ataques com fosfatase alcalina recombinante | |
| NZ713621A (en) | Compounds and methods of treating infections | |
| BR112022002609A2 (pt) | Métodos de tratamento de tumores estromais gastrointestinais | |
| EA201790142A1 (ru) | Лечение лейкоза ингибиторами гистондеацетилазы | |
| MX385578B (es) | Moduladores de canales de kv3 para tratar dolor. | |
| BR112018070017A2 (pt) | métodos de tratamento de cânceres pediátricos | |
| EA201890878A1 (ru) | Способ лечения медуллобластомы с помощью ингибитора ezh2 | |
| MX2021007602A (es) | Derivados de heteroarildihidropirimidina y metodos de tratamiento de infecciones de hepatitis b. | |
| ZA202103975B (en) | Methods of treating disease with magl inhibitors | |
| MX2021004755A (es) | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria. | |
| MX2019015212A (es) | Compuestos para el tratamiento del sarcoma. | |
| PH12021550713A1 (en) | Medicament for the treatment of chronic cough | |
| JOP20210245A1 (ar) | طرق لعلاج الداء النشواني من النوع خفيف السلسلة | |
| MX389282B (es) | Composiciones y métodos para tratar sinucleinopatías. | |
| MX2025000353A (es) | Metodos para tratar el dolor de la superficie ocular |